Research Article | | Peer-Reviewed

The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR

Received: 12 August 2024     Accepted: 2 September 2024     Published: 20 September 2024
Views:       Downloads:
Abstract

Antimicrobial resistance (AMR) has emerged as one of the most formidable challenges to public health security worldwide, threatening the effectiveness of essential medical treatments and the management of infectious diseases. The relentless spread of resistant pathogens compromises the effectiveness of life-saving treatments, leading to longer hospital stays, higher medical costs, and increased mortality. This article delves into the profound and multifaceted impact of AMR, illustrating how it undermines the ability to treat common infections, perform routine surgeries, and manage chronic conditions. The vicious cycle of AMR not only exacerbates the burden on healthcare systems but also threatens to reverse decades of medical progress, potentially plunging the world into a post-antibiotic era where minor infections could once again be fatal. The article further explores the integral role of healthcare systems and policy frameworks in addressing this burgeoning crisis. It discusses how the lack of coordinated global strategies and inconsistent policy implementation have allowed AMR to flourish, emphasizing the need for robust healthcare infrastructures that prioritize the prevention and control of resistance. Critical measures such as enhancing global surveillance systems, promoting antimicrobial stewardship, and fostering innovation in new drug development are identified as pivotal in the fight against AMR. Moreover, the article highlights the importance of policy-driven interventions, including the enforcement of regulations on antibiotic use, investment in public health education, and the integration of AMR action plans into national health policies. By examining successful case studies and identifying gaps in current approaches, the article provides a comprehensive analysis of how healthcare systems and policy can be leveraged to combat AMR effectively. The discussion culminates in a call for a unified global response, underscoring that combating AMR requires not only technological advancements but also sustained political commitment and international collaboration to secure a safer, healthier future for all.

Published in World Journal of Public Health (Volume 9, Issue 3)
DOI 10.11648/j.wjph.20240903.17
Page(s) 286-294
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Antimicrobial Resistance (AMR), Global Health Threats, Public Health Security, Multidrug-Resistant Organisms, Infection Control, Public Health Policy, Healthcare Systems, Antibiotic Stewardship

References
[1] Antimicrobial Resistance Collaborators. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet; 399(10325): P629-655.
[2] Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014 Dec; 5(6): 229-41.
[3] Velazquez-Meza ME, Galarde-López M, Carrillo-Quiróz B, Alpuche-Aranda CM. Antimicrobial resistance: One Health approach. Vet World. 2022 Mar; 15(3): 743-749.
[4] World Health Organization (WHO). "Antimicrobial Resistance: Global Report on Surveillance." 2014.
[5] Centers for Disease Control and Prevention (CDC). "Antibiotic Resistance Threats in the United States." 2019.
[6] World Bank. "Drug-Resistant Infections: A Threat to Our Economic Future." 2017.
[7] Review on Antimicrobial Resistance. "Tackling Drug-Resistant Infections Globally: Final Report and Recommendations." 2016.
[8] World Health Organization (WHO). (2020). Infection prevention and control. Retrieved from WHO.
[9] Centers for Disease Control and Prevention (CDC). (2021). Antibiotic Stewardship. Retrieved from CDC.
[10] World Health Organization (WHO). (2018). Global Antimicrobial Resistance Surveillance System (GLASS) report. Retrieved from WHO.
[11] Tamma, P. D., & Cosgrove, S. E. (2011). Antimicrobial stewardship programs. Clinical Microbiology Reviews, 24(3), 510-548.
[12] Dyar, O. J., et al. (2017). Strategies and challenges of antimicrobial stewardship in resource-limited settings. Journal of Antimicrobial Chemotherapy, 72(11), 2911-2918.
[13] Ogyu A, Chan O, Littmann J, Pang HH, Lining X, Liu P, Matsunaga N, Ohmagari N, Fukuda K, Wernli D. National action to combat AMR: a One-Health approach to assess policy priorities in action plans. BMJ Glob Health. 2020 Jul; 5(7): e002427.
[14] Laxminarayan, R., Duse, A., Wattal, C., et al. (2013). Antibiotic Resistance—the Need for Global Solutions. The Lancet Infectious Diseases, 13(12), 1057-1098.
[15] Dutescu IA, Hillier SA. Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study. Infect Drug Resist. 2021 Feb 5; 14: 415-434.
[16] Renwick, M. J., Brogan, D. M., & Mossialos, E. (2016). A Systematic Review and Critical Assessment of Incentive Strategies for Discovery and Development of Novel Antibiotics. The Journal of Antibiotics, 69(2), 73-88.
[17] Ajulo S, Awosile B. Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries. PLoS One. 2024 Feb 5; 19(2): e0297921.
[18] Hu XY, Logue M, Robinson N. Antimicrobial resistance is a global problem - a UK perspective. Eur J Integr Med. 2020 Jun; 36: 101136.
[19] Köck R, Becker K, Idelevich EA, Jurke A, Glasner C, Hendrix R, Friedrich AW. Prevention and Control of Multidrug-Resistant Bacteria in The Netherlands and Germany-The Impact of Healthcare Structures. Int J Environ Res Public Health. 2020 Mar 30; 17(7): 2337.
[20] Gilham, E. L., Pearce-Smith, N., Carter, V. et al. Assessment of global antimicrobial resistance campaigns conducted to improve public awareness and antimicrobial use behaviours: a rapid systematic review. BMC Public Health 24, 396 (2024).
[21] Sumpradit N, Wongkongkathep S, Malathum K, Janejai N, Paveenkittiporn W, Yingyong T, Chuxnum T, Vijitleela A, Boonyarit P, Akaleephan C, Manosuthi W, Thienthong V, Srinha J, Wongsrichai S, Laoprasert T, Athipunyakom P, Kriengchaiyaprug N, Intarukdach K, Numsawad S, Somjetanakul N, Punnin S, Kiatying-Angsulee N. Thailand's national strategic plan on antimicrobial resistance: progress and challenges. Bull World Health Organ. 2021 Sep 1; 99(9): 661-673.
[22] Sabbatucci M, Ashiru-Oredope D, Barbier L, Bohin E, Bou-Antoun S, Brown C, Clarici A, Fuentes C, Goto T, Maraglino F, Morin J, Rönnefahrt I, Sanwidi A, Triggs-Hodge C, Vitiello A, Zovi A, Gelormini M, Lo Fo Wong D. Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023: opportunities and gaps. Pharmacol Res. 2024 Jun; 204: 107188.
[23] Tangcharoensathien V, Sattayawutthipong W, Kanjanapimai S, Kanpravidth W, Brown R, Sommanustweechai A. Antimicrobial resistance: from global agenda to national strategic plan, Thailand. Bull World Health Organ. 2017 Aug 1; 95(8): 599-603.
[24] Sumpradit N, Wongkongkathep S, Poonpolsup S, Janejai N, Paveenkittiporn W, Boonyarit P, Jaroenpoj S, Kiatying-Angsulee N, Kalpravidh W, Sommanustweechai A, Tangcharoensathien V. New chapter in tackling antimicrobial resistance in Thailand. BMJ. 2017 Sep 5; 358: j3415.
[25] Piddock LJ. Antibiotic action: helping deliver action plans and strategies. Lancet Infect Dis. 2013 Dec; 13(12): 1009-11.
[26] Walsh TR, Gales AC, Laxminarayan R, Dodd PC. Antimicrobial Resistance: Addressing a Global Threat to Humanity. PLoS Med. 2023 Jul 3; 20(7): e1004264.
[27] O'Neill, J. (2016). Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance.
[28] Hollis, A., & Ahmed, Z. (2013). Preserving antibiotics, rationally. New England Journal of Medicine, 369(26), 2474-2476.
[29] Mendelson, M., & Matsoso, M. P. (2015). The World Health Organization Global Action Plan for antimicrobial resistance. South African Medical Journal, 105(5), 325-325.
[30] Chen S, Zhang J, Wu Y. National Action Plan in Antimicrobial Resistance Using Framework Analysis for China. China CDC Wkly. 2023 Jun 2; 5(22): 492-498.
Cite This Article
  • APA Style

    Sultana, M., Perves, N., Uddin, N., Chowdhury, M. K., Amin, N. (2024). The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR. World Journal of Public Health, 9(3), 286-294. https://doi.org/10.11648/j.wjph.20240903.17

    Copy | Download

    ACS Style

    Sultana, M.; Perves, N.; Uddin, N.; Chowdhury, M. K.; Amin, N. The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR. World J. Public Health 2024, 9(3), 286-294. doi: 10.11648/j.wjph.20240903.17

    Copy | Download

    AMA Style

    Sultana M, Perves N, Uddin N, Chowdhury MK, Amin N. The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR. World J Public Health. 2024;9(3):286-294. doi: 10.11648/j.wjph.20240903.17

    Copy | Download

  • @article{10.11648/j.wjph.20240903.17,
      author = {Maleka Sultana and Noman Perves and Nasir Uddin and Mahbub-E-Elahi Khan Chowdhury and Nurul Amin},
      title = {The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR
    },
      journal = {World Journal of Public Health},
      volume = {9},
      number = {3},
      pages = {286-294},
      doi = {10.11648/j.wjph.20240903.17},
      url = {https://doi.org/10.11648/j.wjph.20240903.17},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20240903.17},
      abstract = {Antimicrobial resistance (AMR) has emerged as one of the most formidable challenges to public health security worldwide, threatening the effectiveness of essential medical treatments and the management of infectious diseases. The relentless spread of resistant pathogens compromises the effectiveness of life-saving treatments, leading to longer hospital stays, higher medical costs, and increased mortality. This article delves into the profound and multifaceted impact of AMR, illustrating how it undermines the ability to treat common infections, perform routine surgeries, and manage chronic conditions. The vicious cycle of AMR not only exacerbates the burden on healthcare systems but also threatens to reverse decades of medical progress, potentially plunging the world into a post-antibiotic era where minor infections could once again be fatal. The article further explores the integral role of healthcare systems and policy frameworks in addressing this burgeoning crisis. It discusses how the lack of coordinated global strategies and inconsistent policy implementation have allowed AMR to flourish, emphasizing the need for robust healthcare infrastructures that prioritize the prevention and control of resistance. Critical measures such as enhancing global surveillance systems, promoting antimicrobial stewardship, and fostering innovation in new drug development are identified as pivotal in the fight against AMR. Moreover, the article highlights the importance of policy-driven interventions, including the enforcement of regulations on antibiotic use, investment in public health education, and the integration of AMR action plans into national health policies. By examining successful case studies and identifying gaps in current approaches, the article provides a comprehensive analysis of how healthcare systems and policy can be leveraged to combat AMR effectively. The discussion culminates in a call for a unified global response, underscoring that combating AMR requires not only technological advancements but also sustained political commitment and international collaboration to secure a safer, healthier future for all.
    },
     year = {2024}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - The Vicious Impact of Antimicrobial Resistance on Global Public Health Security and the Role of Healthcare Systems and Policy in Combating AMR
    
    AU  - Maleka Sultana
    AU  - Noman Perves
    AU  - Nasir Uddin
    AU  - Mahbub-E-Elahi Khan Chowdhury
    AU  - Nurul Amin
    Y1  - 2024/09/20
    PY  - 2024
    N1  - https://doi.org/10.11648/j.wjph.20240903.17
    DO  - 10.11648/j.wjph.20240903.17
    T2  - World Journal of Public Health
    JF  - World Journal of Public Health
    JO  - World Journal of Public Health
    SP  - 286
    EP  - 294
    PB  - Science Publishing Group
    SN  - 2637-6059
    UR  - https://doi.org/10.11648/j.wjph.20240903.17
    AB  - Antimicrobial resistance (AMR) has emerged as one of the most formidable challenges to public health security worldwide, threatening the effectiveness of essential medical treatments and the management of infectious diseases. The relentless spread of resistant pathogens compromises the effectiveness of life-saving treatments, leading to longer hospital stays, higher medical costs, and increased mortality. This article delves into the profound and multifaceted impact of AMR, illustrating how it undermines the ability to treat common infections, perform routine surgeries, and manage chronic conditions. The vicious cycle of AMR not only exacerbates the burden on healthcare systems but also threatens to reverse decades of medical progress, potentially plunging the world into a post-antibiotic era where minor infections could once again be fatal. The article further explores the integral role of healthcare systems and policy frameworks in addressing this burgeoning crisis. It discusses how the lack of coordinated global strategies and inconsistent policy implementation have allowed AMR to flourish, emphasizing the need for robust healthcare infrastructures that prioritize the prevention and control of resistance. Critical measures such as enhancing global surveillance systems, promoting antimicrobial stewardship, and fostering innovation in new drug development are identified as pivotal in the fight against AMR. Moreover, the article highlights the importance of policy-driven interventions, including the enforcement of regulations on antibiotic use, investment in public health education, and the integration of AMR action plans into national health policies. By examining successful case studies and identifying gaps in current approaches, the article provides a comprehensive analysis of how healthcare systems and policy can be leveraged to combat AMR effectively. The discussion culminates in a call for a unified global response, underscoring that combating AMR requires not only technological advancements but also sustained political commitment and international collaboration to secure a safer, healthier future for all.
    
    VL  - 9
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Sylhet MAG Osmani Medical College Hospital, Sylhet, Bangladesh

  • Department of Pharmacy, University of Karachi, Karachi, Pakistan; Patient Access and Key Account Management, Novartis Bangladesh Limited, Dhaka, Bangladesh

  • Baylor Scott & White Research Institute, Texas, USA

  • Epidemiology, International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh

  • Department of Applied Chemistry and Chemical Engineering, Faculty of Engineering and Technology, University of Dhaka, Dhaka, Bangladesh

  • Sections